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Abstract
Aim: Several studies have suggested
that lifetime cannabis consumption
and childhood abuse synergistically
contribute to the risk for psychotic
disorders. This study aimed to extend
existing findings regarding an addi-
tive interaction between childhood
abuse and lifetime cannabis use by
investigating the moderating role of
type and frequency of cannabis use.
Methods: Up to 231 individuals pre-
senting for the first time to mental
health services with psychotic disor-
ders and 214 unaffected population
controls from South London, United
Kingdom, were recruited as part of
the Genetics and Psychosis study.
Information about history of canna-
bis use was collected using the Can-
nabis Experiences Questionnaire.
Childhood physical and sexual abuse
was assessed using the Childhood
Experience of Care and Abuse
Questionnaire.
Results:Neither lifetime cannabis use
nor reported exposure to childhood
abuse was associated with psychotic
disorder when the other environmen-
tal variable was taken into account.
Although the combination of the two
risk factors raised the odds for psy-
chosis by nearly three times (adjusted
OR = 2.94, 95% CI: 1.44–6.02, P =
0.003), no evidence of interaction was
found (adjusted OR = 1.46, 95% CI:
−0.54 to 3.46, P = 0.152). Furthermore,
the association of high-potency can-
nabis and daily consumption with
psychosis was at least partially inde-
pendent of the effect of childhood
abuse.
Conclusions: The heavy use of high-
potency cannabis increases the risk of
psychosis but, in addition, smoking of
traditional resin (hash) and less than
daily cannabis use may increase the
risk for psychosis when combined
with exposure to severe childhood
abuse.
Key words: cannabis, childhood trauma, first-episode psychosis, inter-
action, marijuana smoking.
INTRODUCTION
Both childhood maltreatment and cannabis abuse
are considered to play a role in the pathogenesis of
psychosis.1,2 Recent studies indicate that their
effect on psychosis is neither fully confounded
by other risk factors3,4 nor a simple effect of gene–
environment correlation.5 Moreover, there are
suggestions that the risk for psychosis is greater in
subjects exposed to both risk factors compared to
those who experienced only either of them.6–8 For
instance, a preliminary investigation using the US
National Comorbidity Survey found that when can-
nabis use and sexual molestation/rape before 16
years of age were entered into the same model,
neither of them were associated with psychosis,
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but it was only the combination of the two that
increased the risk in a more than multiplicative
way (OR = 11.96, 95% CI 2.10–68.22).6
Subsequent studies have confirmed the interac-
tion between cannabis and trauma, although at an
additive level. In a small sample of adolescents aged
12–15 years, the odds of reporting psychotic symp-
tomswas 20.9 among subjects exposed to both child
abuse and lifetime cannabis use, compared to 1.9
among those exposed only to cannabis, and 2.6 in
those exposed only to trauma.7 Konings et al. repli-
cated this additive interaction in abirth cohort study
(theGreekNational Perinatal Study) and a longitudi-
nal population study (the Netherlands Mental
Health Survey and Incidence Study, NEMESIS). It
was found that the strength of interaction between
lifetime cannabis use and childhood trauma
increased with the frequency of maltreatment sug-
gestingadose-dependent, extra-linear relationship.8
Contrasting with these promising findings, in
anotherDutch study (theEarlyDevelopmental Stage
of Psychopathology) there was no evidence that
broadly defined traumatic experiences before 18
years of age (including, among others, wars, natural
disasters, and serious accidents in addition to physi-
cal and sexual abuse) moderated the effect of
smoking cannabis (five times or more) on psychotic
symptoms.9 One possible reason for the discrepan-
cies in thefindings is thatprevious studiesused fairly
crudemeasures of cannabis use, which often did not
consider frequency of consumption, and may
have included participants using different strengths
of cannabis – higher concentrations of delta9-
tetrahydrocannabinol (Δ9-THC) have been associ-
ated with greater odds of developing psychosis.10
Therefore, the aim of the present study was to
replicate existing findings regarding an additive
interaction between childhood abuse and lifetime
cannabis use in a sample of individuals presenting
for the first time to mental health services with psy-
chotic disorders and to extend these findings by
investigating the moderating role of type and fre-
quency of cannabis use on the association between
childhood abuse and psychosis.
METHODS
Participants
Psychosis cases and unaffected controls were
recruited as part of the Genetics and Psychosis
Study (NIHR-BRC GAP), approved by the South
London & Maudsley National Health Service (NHS)
Trust and the Institute of Psychiatry ethical commit-
tees.10,11 All the participants were informed about
the study aims and provided written informed
consent. Cases were individuals aged 18–65 with a
first episode of psychosis who presented to the
Lambeth, Southwark and Croydon adult inpatient
units of the South London and Maudsley Mental
Health NHS Foundation Trust between December
2005 and October 2010. Cases had to fulfil the Inter-
national Classification of Diseases (ICD-10)12 cri-
teria for psychosis (code F20-29 or F30-34); cases
with a known organic cause for psychosis were
excluded. Diagnoses were formulated by trained
psychiatrists according to Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-
IV)13 and ICD-1012 criteria using the Operational
Criteria system, OPCRIT,14 on the basis of clinical
notes collected for each patient during the first
month after admission. Controls were recruited
from the same catchment area as cases through
leaflet distributions and Internet and newspaper
advertisements. Potential controls were screened
for current or past psychotic disorders using the
Psychosis Screening Questionnaire (PSQ),15 and
those who met the criteria for a psychotic disorder,
or reported a previous diagnosis of psychosis, were
excluded. Subjects with IQ < 70 or poor English
fluency were also excluded.
The data analysed in this paper were limited to
the participants who provided full information
about the two exposures of interest, by completing
both the cannabis and the childhood abuse assess-
ments. Therefore, it includes only 231/489 (47%) of
the patients and 214/278 (77%) of the controls
recruited into the study.11 Reasons for dropout
included the lack of interest in the research, the
length of the assessment and their view of their
mental health.16,17 There were no significant demo-
graphic differences between this subsample and the
full GAP sample, except in the age of the control
group (27.6 ± 9.0 vs. 30.2 ± 9.5, t = 3.120, P = 0.002),
although this only differed on average by 3 years.
Measures
Sociodemographic information (age, gender, self-
rated ethnicity, level of education achieved) and
family history of psychiatric disorder (psychotic dis-
orders, mood disorders or substance/alcohol use
disorders) were collected on both cases and controls
using respectively the Medical Research Council
Sociodemographic Schedule18 and the Family
Interview for Genetic Studies (FIGS).19 Childhood
physical and sexual abuse was assessed using
the Childhood Experience of Care and Abuse Ques-
tionnaire (CECA.Q).20 In order to reduce the pos-
sibility of recall bias and maximize likely effect on
Cannabis and child abuse in psychosis
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psychosis, analyses were limited to physical abuse
resulting in injuries and to penetrative sexual abuse
reported as occurring prior to 17 years of age.
Reports of either of these forms of severe abusewere
considered to indicate exposure to childhood abuse.
Lifetime cannabis use (i.e. having ever smoked
cannabis, one time or more), type of cannabis
most often used and lifetime frequency of cannabis
consumption (i.e. the frequency that characterized
the subject’s most consistent pattern of use) were
investigated using the Cannabis Experiences Ques-
tionnaire modified version (CEQmv).10 The types
of cannabis used by the participants were classified
as mainly resin (hash) versus mainly sinsemilla
(skunk), according to the different concentrations of
Δ9-THC. Δ9-THC is the active principal component
responsible for the psychogenic effect and cognitive
impairments associated with cannabis,21 and is esti-
mated as being 2–4% concentrated in cannabis
resin, but 12–18% in sinsemilla/skunk.22 The life-
time frequency of cannabis consumption was clas-
sified as less than daily versus daily.
Statistical analyses
Analyses were carried out using Stata version 12.0.
Logistic regressionwasused toassess theeffectof the
independent variables on the dependent variable
(presence of psychotic disorder). Analyses were
repeated adjusting for the potentially confounding
effects of gender, self-rated ethnicity, current level of
education, and family psychiatric history, because in
the study sample these variables were associated
either with psychotic disorders or with either of the
two exposures (lifetime cannabis use or childhood
abuse). Statistical interaction is a model-dependent
estimation of biological synergism and refers to a
situation in which the combined effect of two or
more exposures exceeds the sum (additivemodel) or
the product (multiplicative model) of their solitary
effects.23,24 Additive interaction between cannabis
use and childhood abuse was assessed using the
interaction contrast ratio (ICR), which estimates the
relative excess due to interaction using odds ratios
(OR) derived from logistic regressions. In the pres-
ence of statistical interaction, the ICR shows that the
odds of beingpsychotic in those exposed toboth risk
factors is greater than the sum of the odds conveyed
by each risk factor (departure from additivity).25,26
Although the ICR was originally designed to assess
additive interaction in cohort studies, it can be used
in the context of case–control studies under the rare-
diseaseassumption that,when theoutcome is rare in
the source population, ORs approximate risk ratios.
Therefore, we stratified our independent variable
into four levels: those exposed to both cannabis and
child abuse (AB); those exposedonly to cannabis (A);
those exposed only to child abuse (B); and those
exposed to neither cannabis nor child abuse (refer-
ence category). The Stata nlcomcommandwas used
to calculate the ICRs and the related 95% confidence
intervals (CI) and P values.
One issue in interaction studies is that the ‘true’
effect of the interaction may be confounded by cor-
relation,meaning the extent to which one risk factor
can drive the exposure to another risk factor.27 In
this study, Environment by Environment correlation
(rEE) refers to the probability that childhood trauma
per se alters the probability that an individual will
use cannabis. To test rEE, we analysed the effect of
childhood trauma on cannabis use in the control
group using logistic regression. Because of a small
percentage of missing data concerning family psy-
chiatric history, a sensitivity analysis was carried out
to investigate the effect of missingness on the inter-
action between cannabis use and childhood abuse
using an imputationmethod. Post-hoc power analy-
sis was conducted using GPower 3.1.5.
RESULTS
Sociodemographic characteristics of the sample are
reported in Table 1. There was some evidence of a
difference between the psychosis cases and unaf-
fected controls in terms of ethnicity, education level
and family psychiatric history. Furthermore, cases
included a higher proportion of men although there
was no strong evidence of a gender difference
between the groups.
Cannabis use by childhood abuse interaction
There was no evidence of an association between
childhood abuse and cannabis use in the control
group (OR = 0.98, 95% CI 0.46–2.08, P = 0.963), sug-
gesting no evidence of environment–environment
correlation. Table 2 presents the unadjusted and
adjusted ORs for the four combinations of the envi-
ronmental exposures and their associations with
psychotic disorders.
Whereas lifetime cannabis use alone (i.e. in those
without exposure to childhood abuse) and child-
hood abuse alone (i.e. in those with no lifetime
cannabis use) were not associated with psychotic
disorders, the combination of the two exposures
raised the odds for the disease by nearly three times
(adj. OR = 2.94, 95% CI 1.44–6.02, P = 0.003). The
ICR (2.18, 95% CI 0.01–4.36, P = 0.049) was greater
than 0 and showed some evidence of an effect,
L. Sideli et al.
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suggesting that the joint effect of cannabis use and
childhood abuse on the additive scale was greater
than the sum of their effects alone. However, after
adjusting for confounders, the interaction effect was
attenuated and became non-significant (ICR = 1.46,
95% CI −0.54 to 3.46, P = 0.152).
Sensitivity analyses
Family psychiatric history was the only variable to
account for a small percentage of missingness
in this sample (51/445, 11.5%). Missing data were
equally distributed across levels of gender, educa-
tion level, ethnicity, cannabis use and child abuse
but were more frequent in cases than controls
(40 (17.3%) vs. 11 (5.1%), χ2 = 16.2, P < 0.001). All
missing values were replaced first by positive family
history and then by negative family history, and
analyses were repeated using these new variables.
There was no evidence of an interaction after impu-
tation either of a positive (ICR = 1.23, 95% CI −0.35
to 2.81, P = 0.127) or a negative (ICR = 1.53, 95% CI
−0.33 to 3.39, P = 0.107) family history.
Effect of type and frequency of cannabis use
Associations with psychotic disorders for potency
of cannabis consumed (hash-like vs. skunk-like)
and frequency of cannabis use (daily vs. less than
daily) in conjunction with reported exposure to
childhood abuse are presented in Tables 3 and 4,
respectively. Looking at the effect of cannabis alone
or combined with childhood abuse (Tables 3 and 4),
there is a suggestion that high-potency and daily
cannabis users might develop psychotic disorders
at least partially independently of the occurrence
of severe childhood adversities. However, because
of the small sample size, the interaction between
TABLE 1. Demographic characteristics for psychosis cases and unaffected controls
Controls
n (%)
N = 214
Cases
n (%)
N = 231
Chi squared/
Student’s t-test
P value
Gender 3.71 0.054
Male 116 (54.2) 146 (63.2)
Ethnicity 14.16 <0.001
Non-Caucasian 104 (48.6 ) 153 (66.2)
Level of education 38.29 <0.001
Lower than degree 111 (52.1) 183 (79.9)
Age mean (SD) 27.6 (9.0) 28.1 (9.1) −0.59 0.554
Diagnosis
Non-affective psychoses 140 (60.6)
Affective psychoses 44 (19.0)
Controls
n (%)
N = 203
Cases
n (%)
N = 191
Family psychiatric history 75 (37.0) 92 (48.2) 5.07 0.024
SD, standard deviation.
Data in bold: significant at alpha level < 0.05.
TABLE 2. Cannabis use by childhood abuse interaction for psychotic disorders
Controls
n (%)
N = 214
Cases
n (%)
N = 231
OR 95% CI
(P value)
Adj OR† 95% CI
(P value)
No child abuse and no cannabis use 76 (35.5) 58 (25.1) 1 1
Cannabis use without child abuse 105 (49.1) 108 (46.8) 1.35 0.87–2.08 (0.178) 1.43 0.86–2.38 (0.164)
Child abuse without cannabis use 14 (6.5) 12 (5.2) 1.12 0.48–2.61 (0.787) 1.05 0.40–2.74 (0.919)
Child abuse and cannabis use 19 (8.9) 53 (22.9) 3.66 1.96–6.83 (<0.001) 2.94 1.44–6.02 (0.003)
†Adjusted for gender, ethnicity, education level and family psychiatric history.
Adj, adjusted; CI, confidence interval; OR, odds ratio.
Data in bold: significant at alpha level < 0.05.
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childhood abuse and specific patterns of cannabis
use could not be formally tested.
DISCUSSIONS
Cannabis use by childhood abuse interaction
This study found that neither lifetime cannabis
use nor reported exposure to childhood abuse was
associated with psychotic disorder when the other
environmental variable was taken into account. By
contrast, the combination of the two exposures
appeared to exert a significantly greater effect than
the sum of their individual effects suggesting an
additive interaction. Nevertheless, after controlling
for several covariates, this study found no evidence
of interaction between lifetime cannabis use and
childhood abuse. This result is consistent with the
findings of Kuepper et al.,9 who reported that the
effect of smoking cannabis on psychotic symptoms
was not affected by exposure to traumatic events in
childhood or adolescence.
Effect of type and frequency of cannabis use
To our knowledge, this is the first study to investi-
gate the different effects of type and frequency
of cannabis smoking in relation to the association
between childhood abuse and psychosis. Our
results suggest that hash-type cannabis and less
than daily frequency of use are more likely to
combine with childhood abuse in increasing the
odds for psychosis. It could be speculated that the
interaction between cannabis use and childhood
abuse in psychosis is mostly driven by low potency
and less than daily cannabis use. This might explain
why our findings did not replicate the additive inter-
action described by Harley et al.7 and Konings et al.8
On the other hand, high-potency, skunk-like can-
nabis and daily smoking seemed to influence the
pathway to psychosis both alone as well as in asso-
ciation with childhood abuse in this sample. This
confirms the existing literature demonstrating that
individuals affected by psychotic disorders are over
six times more likely to smoke cannabis every day
and to use high-potency cannabis.10,28,29 Further-
more, previous studies have suggested that the
effect of cannabis on psychosis was not confounded
by childhood trauma.28,29 In fact, this is consistent
with the view that in complex multifactorial disor-
ders, such as psychotic disorders, individuals who
are exposed to a variety of risk factorsmight develop
the disease either because of the specific effect of a
particular risk factor (biological parallelism) or
because of a combination of them (biological
synergism).23,30
Potential mechanisms
According to the sensitization hypothesis, geneti-
cally vulnerable individuals exposed early to envi-
ronmental risk factors – including childhood
adversities and certain illicit drugs – might show a
progressive increase in the dopaminergic response
to psychosocial stress that, in turn, might result in
stable changes in dopaminergic reactivity and the
development of psychotic symptoms.31,32 Although
preliminary animal studies have suggested that
housing stress moderates rats’ response to Δ-THC,33
recent evidence suggests that the sensitization
process was bidirectional, so that environmental
stress may affect sensitivity to THC but also that
THC administration alters the endocannabinoid
transmission.34 Despite these promising findings,
the cross-sensitization between environmental
stress and THC has not been fully supported by
human studies.35–37
Limitations
Compared with previous studies that reported
an additive interaction between cannabis and
trauma,7,8 our findings are based on a smaller
sample andmight have been affected by inadequate
power. In fact, post-hoc power analysis based on the
results of the NEMESIS study8 suggests that we had
over 95% power to replicate the difference in the
prevalence of psychosis among cannabis consum-
ers who were also exposed to child abuse (62.5% vs.
26.5%), but only 44% power to replicate the analo-
gous difference in the unexposed group (9.2% vs.
4.8%). This could explain why our study resulted in
weaker findings. To our knowledge, the only other
study reporting traumaby cannabis interactionwith
a similar sample size (N = 211) is the one by Harley
et al.7: the authors reported an ICR of 17.4 which
was suggestive of additive interaction, but the lack
of CIs did not allow evaluation of the significance of
their results. Thus, further studies of the interaction
between cannabis and trauma are warranted.
This study relied on self-reported retrospective
information and, thus, results might have been
affected by recall bias regarding traumatic experi-
ences and use of illicit substances. Despite the fact
that the reliability of psychosis patients’ reports of
earlier abuse has been questioned in the past, a
recent study demonstrated that such reports are
stable over time, consistent between measures and
Cannabis and child abuse in psychosis
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not affected by current symptomatology.38 In our
sample, the prevalence of either physical or sexual
abuse among subjects affected by psychotic disor-
ders was 28% which is higher than rates estimated
for the general population39 but lower than those
reported by literature reviews of prevalence rates
in psychosis patients (50%).40 This might be related
to the very conservative definition of physical and
sexual abuse used in this study, the difficulty in dis-
closure some individuals experience during face-
to-face interviews, or the tendency to underreport
childhood abuse, especially when involving family
members. Reassuringly, though, another first-
episode psychosis sample obtained from an over-
lapping geographical area and using the same
measurement tool – but a less conservative thresh-
old – found almost identical rates of physical and
sexual abuse (31%).41 Previous studies on cannabis
by trauma interaction have used less conservative
definitions of child abuse but still found elevated
rates of psychotic phenomena in those reporting
exposure to child abuse.7,8 As pointed out by several
reviews,40,42 studies on childhood adversities and
psychosis have employed a wide range of measures
and definitions of early traumas, some of which did
not account for severity. Although broader defini-
tions might be more sensitive to minor events and
contribute to greater generalizability of results, use
of narrow definitions of child abuse may be prefer-
able as more severe events are postulated to be
more accurately remembered, thus reducing recall
bias.43 Similar to childhood abuse, cannabis use was
assessed using a semistructured interview, and was
not supported by any biological measure such as a
urine or blood test. However, given that we were
interested in lifetime cannabis use and preferred
type of cannabis use, these biological measures
would not have improved our study because they
are informative only about current consumption.
Indeed, the strength of the association between
cannabis and psychosis was consistent with those
reported by existing literature reviews,2,3 and the
prevalence of lifetime cannabis consumption
among cases and controls (69.7% vs. 57.9%) was
fairly similar to the rates reported in a partially
overlapping sample (62.5% vs. 56.9%).10
Furthermore, it is possible that our findings were
affected by selection bias because our sample
included only 231/489 (47%) of the patients and
214/278 (77%) of the controls recruited into the GAP
study.11 This is because we included only partici-
pants who provided exhaustive information about
both their frequency and type of cannabis use as
well as the type and severity of childhood abuse. In
addition, there was a small proportion of missing
data in one of the covariates (family psychiatric
history), an issue that was addressed by sensitivity
analysis. However, our cases and controls appear
similar to those included by Di Forti et al.11 in terms
of the main demographic variables suggesting their
representativeness of the full study sample.
Conclusions
This study did not replicate previous findings
regarding the synergistic effect of cannabis con-
sumption and childhood abuse on the onset of psy-
chotic disorders. Our findings suggest that, besides
the obvious risk conveyed by heavy use of high-
potency cannabis, smoking resin (hash) and less
than daily smoking are likely to increase the odds for
psychosis when combined with severe childhood
abuse. For that reason, children and adolescents
exposed to physical or sexual abuse might benefit
from psychosocial interventions aimed at pro-
moting adaptive coping strategies and informing
them about the health-related risks of substance
misuse. Clearly replication of these results is
required before clinical trials to test this proposition
could be initiated.
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